Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Director, James Lin, on price transparency regulations , including:

Key implications and considerations for payers, providers and pharma and life sciencesImpacts to consumer behavior and market pricingHow to improve the relationship between price and quality transparency


For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.